Código QR (código de barras bidimensional)

Pharmacogenetics testing for poor response to antidepressants: a transnosographic case series

IntroductionPharmacogenetics (PGx) holds promise for optimizing psychotropic medication use, with CYP2D6 and CYP2C19 identified as key genes in antidepressant treatment. However, few studies have explored the genetic variants of these genes in real-world settings for patients experiencing ineffectiv...

ver descrição completa

Na minha lista:
Principais autores: Marie-Agnès Lorvellec, Gilles Sipahimalani, Bertrand Lahutte, Hervé Delacour, Antoine Baldacci, Emeric Saguin
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2024-10-01
coleção:Frontiers in Pharmacology
Assuntos:
antidepressant
adverse drug reaction
drug response
CYP2D6
CYP2C19
psychiatry
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fphar.2024.1440523/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados